S&P 500

5.277,51

0,80%

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

BIXT

Bioxytran (QB) (BIXT)

Bioxytran Inc (QB)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:BIXT

1 2 3 4 5 6 7 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
09/05/2024	22h43	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:BIXT	Bioxytran Inc (QB)
16/01/2024	16h09	Edgar (US Regulatory)	Form 5 - Annual statement of changes in beneficial ownership of securities	USOTC:BIXT	Bioxytran Inc (QB)
16/01/2024	16h03	Edgar (US Regulatory)	Form 5 - Annual statement of changes in beneficial ownership of securities	USOTC:BIXT	Bioxytran Inc (QB)
16/01/2024	15h53	Edgar (US Regulatory)	Form 5 - Annual statement of changes in beneficial ownership of securities	USOTC:BIXT	Bioxytran Inc (QB)
03/11/2023	02h05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:BIXT	Bioxytran Inc (QB)
03/11/2023	02h02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:BIXT	Bioxytran Inc (QB)
10/10/2023	12h34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:BIXT	Bioxytran Inc (QB)
02/10/2023	17h36	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	USOTC:BIXT	Bioxytran Inc (QB)
02/10/2023	06h15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	USOTC:BIXT	Bioxytran Inc (QB)
26/09/2023	23h04	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	USOTC:BIXT	Bioxytran Inc (QB)
21/09/2023	16h53	Edgar (US Regulatory)	Form DEL AM - Delaying amendment	USOTC:BIXT	Bioxytran Inc (QB)
19/09/2023	19h05	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	USOTC:BIXT	Bioxytran Inc (QB)
24/08/2023	21h09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:BIXT	Bioxytran Inc (QB)
24/08/2023	21h06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:BIXT	Bioxytran Inc (QB)
24/08/2023	20h45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:BIXT	Bioxytran Inc (QB)
24/08/2023	15h15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:BIXT	Bioxytran Inc (QB)
31/07/2023	20h07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:BIXT	Bioxytran Inc (QB)
07/07/2023	15h23	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	USOTC:BIXT	Bioxytran Inc (QB)
30/06/2023	22h58	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	USOTC:BIXT	Bioxytran Inc (QB)
16/06/2023	13h02	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:BIXT	Bioxytran Inc (QB)
12/06/2023	12h45	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:BIXT	Bioxytran Inc (QB)
12/05/2023	12h09	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:BIXT	Bioxytran Inc (QB)
04/05/2023	14h38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BIXT	Bioxytran Inc (QB)
04/05/2023	14h36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BIXT	Bioxytran Inc (QB)
04/05/2023	14h27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BIXT	Bioxytran Inc (QB)
13/03/2023	16h14	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	USOTC:BIXT	Bioxytran Inc (QB)
07/03/2023	23h40	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:BIXT	Bioxytran Inc (QB)
02/03/2023	12h30	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	USOTC:BIXT	Bioxytran Inc (QB)
08/02/2023	20h01	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	USOTC:BIXT	Bioxytran Inc (QB)
08/02/2023	17h41	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	USOTC:BIXT	Bioxytran Inc (QB)